Livedoid vasculopathy: The role of hyperhomocysteinemia and its simple therapeutic consequences

European Journal of Dermatology

Volumn 16, Issue 2, 2006, Pages 159-162

  Meiss, Frank ^a   Marsch, Wolfgang Christian ^a   Fischer, Matthias ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Hypercoagulability; Hyperhomocysteinemia; Livedoid vasculopathy; Thrombophilia

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; CALCIUM ALGINATE; CYANOCOBALAMIN; CYSTATHIONINE BETA SYNTHASE; ENOXAPARIN; FIBRINOPEPTIDE A; FOLIC ACID; FOLIC ACID ANTAGONIST; HOMOCYSTEINE; LOW MOLECULAR WEIGHT HEPARIN; PENTOXIFYLLINE; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN; PYRIDOXINE;

ADULT; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ANTITHROMBIN III DEFICIENCY; ARTICLE; CASE REPORT; CLINICAL FEATURE; CYANOCOBALAMIN DEFICIENCY; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HYDROCOLLOID DRESSING; HYPERCOAGULABILITY; HYPERHOMOCYSTEINEMIA; KIDNEY FAILURE; LIVEDO RETICULARIS; LIVEDOID VASCULOPATHY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERNICIOUS ANEMIA; PROTEIN C DEFICIENCY; PYRIDOXINE DEFICIENCY; RISK FACTOR; SEX RATIO; SKIN BIOPSY; SKIN ULCER; THROMBOPHILIA; ULCER HEALING; VASCULAR DISEASE; VITAMIN SUPPLEMENTATION;

FEMALE; HUMANS; HYPERHOMOCYSTEINEMIA; MIDDLE AGED; SKIN DISEASES, VASCULAR;

EID: 33645564880     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Fritsch P, Zeiger B. Livedo-Vasculitis. Hautarzt 1995; 46: 215-24.
2. Jorizzo JL. Livedoid vasculopathy: what is it? Arch Dermatol 1998; 134: 491-3.
3. Hegemann B, Helmbold P, Marsch WC. Livedoid vasculitis with ulcerations: the role of antithrombin III deficiency and its therapeutic consequences. Arch Dermatol 2002; 138: 841-2.
4. Bard JW, Winkelmann RK. Livedo vasculitis: segmental hyalinizing vasculitis of the dermis. Arch Dermatol 1967; 96: 489-99.
5. Key NS, McGlennen RC. Hyperhomocyst(e)inemia and thrombophilia. Arch Pathol Lab Med 2002; 126: 1367-75.
6. Perna AF, Ingrosso D, Lombardi C, Acanfora F, Satta E, Cesare CM, Violetti E, Romano MM, de Santo NG. Possible mechanisms of homocysteine toxicity. Kidney Int Suppl 2003; 63: S137-S140.
7. Kazory A, Ducloux D. Acquired hypercoagulable state in renal transplant recipients. Thromb Haemost 2004; 91: 646-54.
8. Malinow MR, Bostom AG, Krauss RM. Homocyst(e)ine, diet and cardiovascular diseases: A statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 1999; 99: 178-82.
9. Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, Dierkes J, Weger M. Konsensuspapier der D.A.CH.-Liga Homocystein über den rationellen klinischen Umgang mit Homocystein, Folsäure und B-Vitaminen bei kardiovaskulären und thrombotischen Erkrankungen - Richtlinien und Empfehlungen. J Kardiol 2003; 10: 190-9.
10. Baccard M, Vignon-Pennamen MD, Jannier M, Scorbohaci ML, Dubertret L. Livedo vasculitis with protein C system deficiency. Arch Dermatol 1992; 128: 1410-1.
11. Acland KM, Darvay A, Wakelin SH, Russell-Jones R. Livedoid vasculitis: a manifestation of the antiphospholipid syndrome? Br J Dermatol 1999; 140: 131-5.
12. Calamia KT, Balabanova M, Perniciaro C, Walsh JS. Livedo (livedoid) vasculitis and the factor V Leiden mutation: additional evidence for abnormal coagulation. J Am Acad Dermatol 2002; 46: 133-7.
13. Gotlib J, Kohler S, Reicherter P, Oro AE, Zehnder JL. Heterozygotous prothrombin G20210A gene mutation in a patient with Ovedoid vasculitis. Arch Dermatol 2003; 139: 1081-3.
14. Klein KL, Pittelkow MR. Tissue plasminogen activator for the treatment of livedoid vasculitis. Mayo Clin Proc 1992; 67: 923-33.
15. Pizzo SV, Murray JC, Gonias SL. Atrophie blanche: disorder associated with defective release of tissue plasminogen activator. Arch Pathol Lab Med 1980; 110: 517-9.
16. Wakelin SH, Ellis JP, Black MM. Livedoid vasculitis with anticardiolipin antibodies: improvement with danazol. Br J Dermatol 1998; 139: 935-7.
17. Gibson GE, Li H, Pittelkow MR. Homocysteinemia and livedoid vasculitis. J Am Acad Dermatol 1999; 40: 279-81.
18. Austen SK, Coombes JS, Fassett RG. Homocysteine-lowering therapy in renal disease. Clin Nephrol 2003; 60: 375-85.
19. Undas A, Dogmala TB, Jankowski M, Szczeklik A. Treatment of hyperhomocysteinemia with folic acid and vitamins B12 and B6 attenuates thrombin generation. Thromb Res 1999; 95: 281-8.